ArticlePathology oncology research : POR2017
Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival.
Christian Niedworok et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it